We are No Longer Accepting Reglan Injury Cases.
Research shows that the chronic use of prescription drug metoclopramide,
commonly known as Reglan®, can cause tardive dyskinesia.
Tardive dyskinesia is a disabling and often permanent condition characterized by involuntary and repetitive movements. There is no known treatment for this disfiguring condition which can last a lifetime; affecting a victim physically, mentally, emotionally, socially and vocationally.
Symptoms of tardive dyskinesia include:
- Involuntary/repetitive movements
of the extremities
- Lip smacking, pursing and puckering
- Tongue protrusion
- Rapid eye movements or blinking
- Impaired movement of the fingers
- Constant movement foot tapping:
- Restless leg syndrome
According to the Food and Drug Administration (FDA), two studies have found that the risk of tardive dyskinesia is as high as 29 percent in long term metoclopramide patients. The FDA also says that more than 2 million Americans use metoclopramide products.
What is (Reglan®) Metoclopramide?
Metoclopramide is a prescription drug that increases muscle contractions in the stomach and small intestine, helping the passage of food. Reglan® is prescribed to treat the symptoms of gastroesophageal reflux disease (GERD). It is also prescribed for the treatment of diabetic gastroparesis, a condition in which the stomach does not contract. Metoclopramide is available in a variety of formulations (pills/tablets, syrups and injections) and has been marketed under the names Reglan®, Octamide®, Maxolon®, Degan®, Maxeran®, Primperan®, Reclomide® and Pylomid®.
Reglan®, in its injectable form, has been approved by the FDA for the treatment of nausea and vomiting associated with cancer chemotherapy. The injectable solution has also been approved to prevent the nausea or vomiting that may occur after surgery.